Goal-oriented therapy with miglustat in Gaucher disease

By Pastores Gregory M.   Giraldo Pilar   Chérin Patrick   Mehta Atul  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 23-37

Informa Healthcare

Access to resources Recommend Favorite

Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease

By Matzner Ulrich   Matthes Frank   Weigelt Cecilia   Andersson Claes   Eistrup Carl   Fogh Jens   Gieselmann Volkmar  

Journal of Molecular Medicine, Vol. 86, Iss. 4, 2008-04 ,pp. : 433-442

Springer Publishing Company

Access to resources Recommend Favorite

Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses

By Kloska Anna  

Metabolic Brain Disease, Vol. 26, Iss. 1, 2011-03 ,pp. : 1-8

Springer Publishing Company

Access to resources Recommend Favorite

Genetic basis of the lipid storage disorders

By Wasserstein Melissa P   McGovern Margaret M  

Future Lipidology, Vol. 3, Iss. 2, 2008-04 ,pp. : 189-201

Future Medicine

Access to resources Recommend Favorite

Zolpidem Therapy for Movement Disorders

By  

Recent Patents on CNS Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 55-60

Bentham Science Publishers

Access to resources Recommend Favorite